HOME >> BIOLOGY >> NEWS
Self-correcting embryos could be an ethically acceptable source of embryonic stem cells

normalised cultures, and more are being developed. So far no stem cells from completely abnormal embryos have been developed.

Although the mechanism by which the embryos self-corrected their abnormalities was not clear, Dr Munn believed that it probably happened when a trisomic embryo (one with three of a particular chromosome instead of the usual two) lost the third chromosome somewhere between the time that the fertilised egg first started to divide and the blastocyst stage. "However, not all the embryos were trisomic. Some had other abnormalities, namely chaotic mosaics, with all the cells abnormal but each one different from the others. These did not produce stem cells," said Dr Munn. "It is impossible to tell at this stage which embryos are capable of self-correcting and which are not."

Dr Munn's findings offer researchers an opportunity to research early embryonic development and stem cells without embryos needing to be specially created for the purpose. The embryos he used would have been discarded by couples seeking fertility treatment, after PGD showed that there were abnormalities that meant the embryos would either fail to implant, or spontaneously abort at some point in the pregnancy, or would result in the birth of a child with one of the defects that the couple were trying to avoid by having PGD in the first place.

"The use of human embryos or their purposeful creation for stem cell research has been controversial, and a ban on research using government funds has been in effect in the USA since 2001. These findings offer scientists the chance to continue their research in this important field, without having to create embryos especially for the purpose," said Dr Munn.


'"/>

Contact: Mary Rice
mary@mrcommunication.org
European Society for Human Reproduction and Embryology
20-Jun-2005


Page: 1 2

Related biology news :

1. Germanys embryo protection law is killing embryos rather than protecting them
2. Time-lapse recordings reveal why IVF embryos are more likely to develop into twins
3. Study: Donated embryos could result in more than 2,000 new embryonic stem cell lines
4. Changes in chromosomal constitution of preimplantation embryos suggest caution in genetic screening
5. Cold Spring Harbor Protocols features methods to understand embryos, clones, stem cells
6. Many couples choose to donate surplus embryos for stem cell research
7. In early embryos, cilia get the message across
8. Successful transplantation from pig embryos to mice
9. How IVF could be causing genetic errors in embryos
10. Researchers report technique for freezing and preserving genetically enhanced pig embryos
11. Forsyth scientists gain greater understanding of how embryos differentiate left from right

Post Your Comments:
(Date:12/5/2014)... -- Tute Genomics, a leader in cloud-based solutions for genome ... led by UK-based Eurovestech. Peak Ventures and a number ... "We are at a pivotal time in ... seeks new approaches for the diagnosis, treatment and prevention ... and CEO of Tute Genomics. "One of the main ...
(Date:11/21/2014)... Nov. 19, 2014  Earlier this year Donald ... College, and one of the most prolific inventors in ... are transmitted from Smartphones to third party agencies. Spector ... has one of the earliest known patents in this ... in the military, child care, elder care and hospital ...
(Date:11/18/2014)... 17, 2014   News Highlights: ... to develop The Partners Data Lake, an agile ... Data Lake will allow researcher and clinicians to ... and the lives of patients , The ... activities across the Partners system, breaking down physical ...
Breaking Biology News(10 mins):Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 3Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 5
(Date:12/19/2014)... --  ISN has released its third annual U.S. ... publication series. With data aggregated from over eight billion ... its online contractor management platform, ISNetworld, this three-part series ... statistics. The Contractor Performance ... available in two industry specific volumes: Oil & ...
(Date:12/17/2014)... 17, 2014 Achim Noack has been ... Stoller Group. In this position, Noack will assist Jerry ... matters, develop marketing strategy and supervise global marketing management ... “Achim has tremendous knowledge and experience in the crop ... “His experience and innovative thinking will be a great ...
(Date:12/17/2014)... 17, 2014 Gene synthesis and ... has entered into a technology access and services ... apply DNA2.0’s proprietary protein engineering technology, known as ... “We are extremely excited that the global leader ... This proprietary bioengineering technology has now been validated ...
(Date:12/17/2014)... Dec. 17, 2014 Tigercat Pharma, Inc. ... study evaluating the investigational oral NK-1 receptor antagonist ... severe, chronic itch who are unresponsive or inadequately ... topical steroids and antihistamines. The ... Analog Scale (VAS) itch score from baseline, comparing ...
Breaking Biology Technology:ISN Releases Third Edition of US Contractor Health & Safety Performance Indicators Publication Series 2ISN Releases Third Edition of US Contractor Health & Safety Performance Indicators Publication Series 3Achim Noack Joins Stoller Group as Global Vice President of Marketing and Administration 2ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4
Cached News: